US 7108986
Glypican-1 in human breast cancer
granted A61KA61K2039/505
Quick answer
US patent 7108986 (Glypican-1 in human breast cancer) held by The Regents of the University of California expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/505